| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.004 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |